Dynamic Changes and Clinical Significance of Serum MMP-3 and MMP-9 in Patients with Cerebral Infarction
LI Hong-g
Abstract
LI Hong-g
Abstract
Objective: To investigate the dynamic changes and clinical significance of serum matrix metalloproteinase-3(MMP-3) and matrix metalloproteinase-9(MMP-9) on various stages in patients with cerebral infarction.Methods: 62 cerebral infarction and lacunar infarction patients were divided into the observation group one and the observation group two,while 30 healthy people served as the control group.Serum MMP-3 and MMP-9 levels and the scores of the Clinical Neurological Function Deficient(CNFDS) were measured during the onset 2 to 5 days and 15 days in the observation group and the control group.Results: The levels of serum MMP-9 and MMP-3 during 2 to 5 days of the cerebral infarction were higher than those in the control group(P0.01).The serum MMP-9 levels in the observation group one were significantly higher than those in the observation group two(P0.01).The levels of serum MMP-3 and MMP-9 at the onset 15 days of the observation groups had no significant difference compared with those of the control group.Correlation analysis showed that there was a negative correlation between MMP-9,MMP-3 and prognosis.Conclusion: MMP-3 and MMP-9 may contribute to the pathologic course in the early stage of cerebral infarction.The levels of MMP-3 and MMP-9 are correlated with the clinical course of the disease and prognosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the dynamic changes and clinical significance of serum matrix metalloproteinase-3(MMP-3) and matrix metalloproteinase-9(MMP-9) on various stages in patients with cerebral infarction.Methods: 62 cerebral infarction and lacunar infarction patients were divided into the observation group one and the observation group two,while 30 healthy people served as the control group.Serum MMP-3 and MMP-9 levels and the scores of the Clinical Neurological Function Deficient(CNFDS) were measured during the onset 2 to 5 days and 15 days in the observation group and the control group.Results: The levels of serum MMP-9 and MMP-3 during 2 to 5 days of the cerebral infarction were higher than those in the control group(P0.01).The serum MMP-9 levels in the observation group one were significantly higher than those in the observation group two(P0.01).The levels of serum MMP-3 and MMP-9 at the onset 15 days of the observation groups had no significant difference compared with those of the control group.Correlation analysis showed that there was a negative correlation between MMP-9,MMP-3 and prognosis.Conclusion: MMP-3 and MMP-9 may contribute to the pathologic course in the early stage of cerebral infarction.The levels of MMP-3 and MMP-9 are correlated with the clinical course of the disease and prognosis.
Key concepts: Cerebral infarction, Matrix metalloproteinase, Medicine, Clinical significance, Internal medicine, Infarction, Gastroenterology, Positive correlation